COMMUNIQUÉS West-GlobeNewswire

-
Sanofi: Disclosure of trading in own shares
25/06/2018 -
Sanofi : Déclaration des transactions sur actions propres
25/06/2018 -
Ossur Hf : Transactions in relation to share buyback program
25/06/2018 -
EUROBIO SCIENTIFIC VA COMMERCIALISER LA GAMME TRIAGE® DE QUIDEL
25/06/2018 -
Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes
25/06/2018 -
Gefion Group Investments A/S provisionally extends offer period
25/06/2018 -
Scapa Healthcare Closed Fiscal Year with Significant Enhancements of Capabilities and Technologies
25/06/2018 -
Align Technology Reaches One Millionth Invisalign(R) Patient in the EMEA Region
25/06/2018 -
“Grindeks” completes acquisition of “HBM Pharma” s.r.o.
25/06/2018 -
ViroGates A/S: Registration of capital increase and admission to trading
25/06/2018 -
MannKind Set to Join Russell 3000® Index
25/06/2018 -
La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA™ (angiotensin II)
25/06/2018 -
BlissCo Executing Its Plan, Oils and Extracts Up Next -- CFN Media
25/06/2018 -
Microbot Medical Strengthens Global IP with Issued Patent in India Covering the Company’s ViRob™ Technology Platform
25/06/2018 -
High Hampton Expands Strategic Network in California -- CFN Media
25/06/2018 -
ORYZON announces First Patients in the UK in ETHERAL: a Phase IIa clinical trial in Alzheimer’s Disease with ORY-2001
25/06/2018 -
Marrone Bio Innovations Joins the Russell 2000 Index
25/06/2018 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
25/06/2018 -
Vericel Added to Russell 3000® Index
25/06/2018
Pages